🇺🇸 FDA
Pipeline program

Trichosanthes root

CMUH105-REC2-052

Phase 3 small_molecule active

Quick answer

Trichosanthes root for Diabetes Mellitus is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Diabetes Mellitus
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials